Production (Stage)
Exagen Inc.
XGN
$6.60
$0.579.45%
NASDAQ
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Revenue | 7.51% | -0.80% | -6.78% | 6.56% | 28.36% |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | 7.51% | -0.80% | -6.78% | 6.56% | 28.36% |
Cost of Revenue | 9.59% | -7.86% | -3.22% | 2.95% | -1.84% |
Gross Profit | 6.11% | 4.08% | -9.41% | 9.10% | 62.10% |
SG&A Expenses | 6.28% | -16.47% | -10.65% | -12.46% | -11.29% |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 8.30% | -9.91% | -7.11% | -7.35% | -8.02% |
Operating Income | -12.05% | 34.27% | 8.01% | 47.37% | 61.03% |
Income Before Tax | -11.67% | 32.33% | 7.15% | 40.83% | 56.30% |
Income Tax Expenses | -- | -63.64% | -- | -- | -- |
Earnings from Continuing Operations | -11.67% | 32.51% | 7.15% | 40.83% | 56.30% |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -11.67% | 32.51% | 7.15% | 40.83% | 56.30% |
EBIT | -12.05% | 34.27% | 8.01% | 47.37% | 61.03% |
EBITDA | -14.93% | 36.03% | 5.00% | 51.09% | 64.42% |
EPS Basic | -8.01% | 34.69% | 10.03% | 42.51% | 57.32% |
Normalized Basic EPS | -8.03% | 34.47% | 10.04% | 42.54% | 57.33% |
EPS Diluted | -8.01% | 34.69% | 10.03% | 42.51% | 57.32% |
Normalized Diluted EPS | -8.03% | 34.47% | 10.04% | 42.54% | 57.33% |
Average Basic Shares Outstanding | 3.42% | 3.32% | 3.18% | 2.96% | 2.38% |
Average Diluted Shares Outstanding | 3.42% | 3.32% | 3.18% | 2.96% | 2.38% |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |